Document is current
Any future updates will be listed below
-
Authors
Zhang, Qi
Zhang, Jian
Zhong, Haijun
Yuan, Ying
Yang, Lei
Zhang, Qingyuan
Ji, Dongmei
Gong, Jifang
Li, Jing
Yao, Zhenling
Qi, Chuan
Wang, Jianming
Lu, Lingmin
Shi, Michael
Qian, Xueming
Shen, Lin
Li, Jian
Hu, Xichun
-
Funding
Funding for this research was provided by:
This study was funded by Suzhou Transcenta Therapeutics Co., Ltd, a wholly owned subsidiary of Transcneta Holding Limited.
- License Information
-
More Information
Article History
Received: 22 April 2022
Accepted: 22 March 2023
First Online: 28 April 2023
Declarations
:
: Jing Li, Zhenling Yao, Chuan Qi, Jianming Wang, Lingmin Lu, Michael Shi and Xueming Qian are employees of Transcenta Holding Limited and own stock of Transcenta. The other authors declare that they have no competing interests.
: This study was approved by the institutes' medical ethics committee and was conducted in accordance with the Declaration of Helsinki and guidelines for Good Clinical Practice. The study was registered at ExternalRef removed (NCT04272944).
: Written informed consent was obtained from all patients prior to enrolment.
